Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Gastro Hep Advances|August 12, 2024
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention StrategyKenneth K Tanabe, David Zahrieh, Carrie A Strand, et al.
Annals of Surgical Oncology|May 30, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) SubstudyTina J Hieken, Thomas J Flotte, David Zahrieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trialsBernhard C Pestalozzi, David Zahrieh, Elizabeth Mallon, et al.
Blood|September 1, 2005
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemiaJohn G Gribben, David Zahrieh, Katherine Stephans, et al.
Journal of the National Cancer Institute. Monographs|February 24, 2025
Intracluster correlation coefficients from cluster randomized trials conducted within the NCI Community Oncology Research Program (NCORP)Anna C Snavely, Heather J Gunn, Ju-Whei Lee, et al.
Clinical Breast Cancer|July 25, 2008
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37Irene L Wapnir, Stefan Aebi, Charles E Geyer, et al.
Scientific Reports|January 12, 2023
PDJ amplicon in triple negative breast cancerAlexander S Roesler, Smriti Malasi, Lori Koslosky, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 14, 2021
The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical TrialMarie E Wood, Heshan Liu, Elizabeth Storrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemiaEyal C Attar, Daniel J De Angelo, Jeffrey G Supko, et al.
NPJ Breast Cancer|March 30, 2024
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancerRoberto A Leon-Ferre, Jodi M Carter, David Zahrieh, et al.
Pageof 9